ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 656,51
0,26%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Scopus BioPharma Inc (SCPS)

  7. Scopus BioPharma Inc (SCPS) Actualités

SCPS

Scopus BioPharma (SCPS)

Scopus BioPharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SCPS
DateHeureSourceTitreSymboleSociété
02/11/202314h15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
28/06/202323h16Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:SCPSScopus BioPharma Inc
12/05/202323h16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
28/04/202323h05Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
14/04/202323h01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
16/12/202212h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
02/12/202223h17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SCPSScopus BioPharma Inc
15/11/202223h16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SCPSScopus BioPharma Inc
10/11/202215h15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
18/10/202215h25GlobeNewswire Inc.Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueNASDAQ:SCPSScopus BioPharma Inc
05/05/202214h30GlobeNewswire Inc.Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsNASDAQ:SCPSScopus BioPharma Inc
01/04/202223h17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:SCPSScopus BioPharma Inc
23/03/202201h30GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitNASDAQ:SCPSScopus BioPharma Inc
20/01/202214h35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:SCPSScopus BioPharma Inc
19/01/202212h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCPSScopus BioPharma Inc
10/01/202214h30GlobeNewswire Inc.Scopus BioPharma Provides Update Following Annual Meeting of StockholdersNASDAQ:SCPSScopus BioPharma Inc
10/01/202214h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SCPSScopus BioPharma Inc
06/01/202213h00PR Newswire (US)DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORSNASDAQ:SCPSScopus BioPharma Inc
05/01/202222h51Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:SCPSScopus BioPharma Inc
04/01/202212h05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SCPSScopus BioPharma Inc
17/12/202114h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCPSScopus BioPharma Inc
17/12/202114h00GlobeNewswire Inc.Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the CompanyNASDAQ:SCPSScopus BioPharma Inc
07/12/202123h24Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SCPSScopus BioPharma Inc
07/12/202114h30GlobeNewswire Inc.Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy CardNASDAQ:SCPSScopus BioPharma Inc
06/12/202113h00PR Newswire (US)Dr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual MeetingNASDAQ:SCPSScopus BioPharma Inc
26/11/202123h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPSScopus BioPharma Inc
22/11/202114h00GlobeNewswire Inc.Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-MarketNASDAQ:SCPSScopus BioPharma Inc
08/11/202114h00GlobeNewswire Inc.Scopus BioPharma Announces Adjournment of Annual Meeting of StockholdersNASDAQ:SCPSScopus BioPharma Inc
06/10/202121h07Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:SCPSScopus BioPharma Inc
05/10/202114h45GlobeNewswire Inc.Scopus BioPharma to Present at the LD Micro Main EventNASDAQ:SCPSScopus BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:SCPS

Dernières Valeurs Consultées

EU
SGE2D
Euronext G EDF 151121 De...
LSE
HS96
Citi Fun 24
NASDAQ
AAZQQXX
Jpmorgan Chase Financial...
LSE
92MV
Equinor 31
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés